![HIPEC and cytoreductive surgery do not improve outcomes over cytoreductive surgery alone in patients with platinum-sensitive recurrent ovarian cancer - Mayo Clinic HIPEC and cytoreductive surgery do not improve outcomes over cytoreductive surgery alone in patients with platinum-sensitive recurrent ovarian cancer - Mayo Clinic](https://www.mayoclinic.org/-/media/kcms/gbs/medical-professionals/images/2021/12/17/16/35/hipec-mc1crmd-767wx535h.jpg)
HIPEC and cytoreductive surgery do not improve outcomes over cytoreductive surgery alone in patients with platinum-sensitive recurrent ovarian cancer - Mayo Clinic
![Frontiers | Elevated temperatures and longer durations improve the efficacy of oxaliplatin- and mitomycin C-based hyperthermic intraperitoneal chemotherapy in a confirmed rat model for peritoneal metastasis of colorectal cancer origin Frontiers | Elevated temperatures and longer durations improve the efficacy of oxaliplatin- and mitomycin C-based hyperthermic intraperitoneal chemotherapy in a confirmed rat model for peritoneal metastasis of colorectal cancer origin](https://www.frontiersin.org/files/Articles/1122755/fonc-13-1122755-HTML-r1/image_m/fonc-13-1122755-g001.jpg)
Frontiers | Elevated temperatures and longer durations improve the efficacy of oxaliplatin- and mitomycin C-based hyperthermic intraperitoneal chemotherapy in a confirmed rat model for peritoneal metastasis of colorectal cancer origin
![Adjuvant hyperthermic intraperitoneal chemotherapy in patients with locally advanced colon cancer (COLOPEC): a multicentre, open-label, randomised trial - The Lancet Gastroenterology & Hepatology Adjuvant hyperthermic intraperitoneal chemotherapy in patients with locally advanced colon cancer (COLOPEC): a multicentre, open-label, randomised trial - The Lancet Gastroenterology & Hepatology](https://www.thelancet.com/cms/attachment/050b3863-29ed-4b1f-b646-521e01bb61d4/gr1_lrg.gif)
Adjuvant hyperthermic intraperitoneal chemotherapy in patients with locally advanced colon cancer (COLOPEC): a multicentre, open-label, randomised trial - The Lancet Gastroenterology & Hepatology
![HIPEC OVHIPEC PMP peritoneal cancer peritoneum seeding seedings metastases hyperthermic intraperitoneal chemotherapy debulking colon colorectal ovarian ovary mesothelioma pseudomyxoma appendix HIPEC OVHIPEC PMP peritoneal cancer peritoneum seeding seedings metastases hyperthermic intraperitoneal chemotherapy debulking colon colorectal ovarian ovary mesothelioma pseudomyxoma appendix](https://drmulier.com/exploratie%20hipec.jpg)
HIPEC OVHIPEC PMP peritoneal cancer peritoneum seeding seedings metastases hyperthermic intraperitoneal chemotherapy debulking colon colorectal ovarian ovary mesothelioma pseudomyxoma appendix
![Flow-diagram GECOP-MMC trial. PM-CC: peritoneal metastases from colon... | Download Scientific Diagram Flow-diagram GECOP-MMC trial. PM-CC: peritoneal metastases from colon... | Download Scientific Diagram](https://www.researchgate.net/publication/360554071/figure/fig1/AS:1155094594756618@1652407420502/Flow-diagram-GECOP-MMC-trial-PM-CC-peritoneal-metastases-from-colon-cancer-PCI.png)
Flow-diagram GECOP-MMC trial. PM-CC: peritoneal metastases from colon... | Download Scientific Diagram
Dr. Archit Pandit - HIPEC - HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY❗️ Why HIPEC? Hyperthermic Intraperitoneal Chemotherapy (HIPEC) is a surgical process that's giving new hope to patients with abdominal cancers. Immediately after removing visible
![Combined liver resection and cytoreductive surgery with HIPEC for metastatic colorectal cancer: Results of a worldwide analysis of 565 patients from the Peritoneal Surface Oncology Group International (PSOGI) - ScienceDirect Combined liver resection and cytoreductive surgery with HIPEC for metastatic colorectal cancer: Results of a worldwide analysis of 565 patients from the Peritoneal Surface Oncology Group International (PSOGI) - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0748798320306661-gr1.jpg)
Combined liver resection and cytoreductive surgery with HIPEC for metastatic colorectal cancer: Results of a worldwide analysis of 565 patients from the Peritoneal Surface Oncology Group International (PSOGI) - ScienceDirect
![Impact of KRAS, BRAF and microsatellite instability status after cytoreductive surgery and HIPEC in a national cohort of colorectal peritoneal metastasis patients | British Journal of Cancer Impact of KRAS, BRAF and microsatellite instability status after cytoreductive surgery and HIPEC in a national cohort of colorectal peritoneal metastasis patients | British Journal of Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41416-021-01620-6/MediaObjects/41416_2021_1620_Fig1_HTML.png)
Impact of KRAS, BRAF and microsatellite instability status after cytoreductive surgery and HIPEC in a national cohort of colorectal peritoneal metastasis patients | British Journal of Cancer
Prophylactic surgery plus hyperthermic intraperitoneal chemotherapy (HIPEC CO2) versus standard surgery in colorectal carcinoma
![HIPEC OVHIPEC PMP peritoneal cancer peritoneum seeding seedings metastases hyperthermic intraperitoneal chemotherapy debulking colon colorectal ovarian ovary mesothelioma pseudomyxoma appendix HIPEC OVHIPEC PMP peritoneal cancer peritoneum seeding seedings metastases hyperthermic intraperitoneal chemotherapy debulking colon colorectal ovarian ovary mesothelioma pseudomyxoma appendix](https://drmulier.com/hipec%20en%201.jpg)
HIPEC OVHIPEC PMP peritoneal cancer peritoneum seeding seedings metastases hyperthermic intraperitoneal chemotherapy debulking colon colorectal ovarian ovary mesothelioma pseudomyxoma appendix
![HIPEC OVHIPEC PMP peritoneal cancer peritoneum seeding seedings metastases hyperthermic intraperitoneal chemotherapy debulking colon colorectal ovarian ovary mesothelioma pseudomyxoma appendix HIPEC OVHIPEC PMP peritoneal cancer peritoneum seeding seedings metastases hyperthermic intraperitoneal chemotherapy debulking colon colorectal ovarian ovary mesothelioma pseudomyxoma appendix](https://drmulier.com/hipec%20en%202.jpg)